Publications and communications of Adrien DE VOEGHT

Somja, J., Collins, P., Keutgens, A., De Voeght, A., & Tassin, F. (2026). Charcot–Leyden Crystals in AML With NPM1 Mutation. International Journal of Laboratory Hematology. doi:10.1111/ijlh.70073

E Silva, B.* , Daubry, A.* , Faville, C.* , De Voeght, A., Foguenne, J., Jassin, M., Kwan, O., Correia Da Cruz, L., Carriglio, G., Charles, S., Baron, F., Caers, J., Gothot, A., & Ehx, G. (2026). Biases introduced by Ficoll-based isolation in acute myeloid leukemia sample analyses support the use of hemolysis. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/342923. doi:10.64898/2026.02.11.705243
* These authors have contributed equally to this work.

De Voeght, A., Bodart, F., Baron, F., & Louppe, G. (06 February 2026). MARVIN: A Deep Generative Model for Flow Cytometry Analysis Informed by Biological Assumption [Poster presentation]. 41st General Annual Meeting of the Belgian Hematology Society.

Lemhamdi, O., Willems, E., Baron, F., DE PRIJCK, B., Caers, J., Bouquegneau, A., Guiot, J., Cousin, F., Jadoul, A., Rogister, F., Frippiat, F., Hayette, M.-P., & De Voeght, A. (04 February 2026). Novel diagnostic approaches and therapeutic management of mucormycosis: insights from a retrospective monocentric cohort study. Frontiers in Medicine, 13. doi:10.3389/fmed.2026.1715663

Chauffier, J., Jachiet, V., Battistella, M., Romero, P., Fenaux, P., Zakine, E., Zhao, L. P., Mahévas, T., Bouaziz, J.-D., Hadjadj, J., Amoura, Z., Mathian, A., Breillat, P., Hirsch, P., Bourguiba, R., De Voeght, A., Grobost, V., Begon, E., Jandus, P., ... EMSED Group and MINHEMON Group. (2025). Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia. JAMA Dermatology. doi:10.1001/jamadermatol.2025.4586

De Voeght, A., Bodart, F., Baron, F., & Louppe, G. (03 November 2025). Marvin: Deep generative model with structured latent space for flow cytometry cell classification and discovery of new population [Poster presentation]. Congress of the American Society of Hematology, Orlando, United States. doi:10.1182/blood-2025-6132

Stammler, R., Chen, P., Debeaupuis, O., Zhao, L. P., Ruyer‐Thompson, M., Zakine, E., Rossignol, J., Goldwirt, L., Comont, T., Heiblig, M., Adès, L., Sebert, M., Allain, J. S., Campagne, J., Couturier, M. A., Cumin, M., Dalmas, M. C., Denis, G., Devloo, C., ... Mékinian, A. (November 2025). Inflammatory disorders in IDH‐mutated myeloid neoplasms: Characteristics and response to IDH inhibitors. HemaSphere, 9 (11). doi:10.1002/hem3.70256

Lopez Delhoulle, V., De Voeght, A., NECHIFOR - POTORAC, I., Sépulchre, E., Willems, E., Pétrossians, P., Fernandez Carazo, R., KOOPMANSCH, B., Docampo Martínez, E., Bours, V., Bulk, S.* , & Lambert, F.*. (16 October 2025). A Spectrum of Tumorigenesis in an IDH1-Mosaic Patient with Ollier Disease [Poster presentation]. 7th INTERNATIONAL CONFERENCE ACUTE MYELOID LEUKEMIA “MOLECULAR AND TRANSLATIONAL”: ADVANCES IN BIOLOGY AND TREATMENT, Estoril, Portugal.
* These authors have contributed equally to this work.

Maertens, J., R. Herbrecht, S. Fodil, De Voeght, A., K. Delavigne, T. Liebregts, R. Rodriguez Veiga, J. De Greef, M. Uzunov, L. Vazquez10, O. Penack, A. Albasanz-Puig, M.C. Ngirabacu, V. Mehra, D. Teschner, L. Albert, C. Pfeifer, P. Brennan-Benson, K. Vanstraelen, & E. Azoulay. (July 2025). Real-world dataset demonstrates favorable safety profile of liposomal amphotericin B for the treatment of invasive aspergillosis in high-risk haemato-oncology patients [Poster presentation]. ESCMID Global 2025.

Lukas Haaksma, Gwendolyn Van Gorkom, Tom Reuvekamp, Andrius Žučenka, De Voeght, A., Vladimir Lazarevic, Dries Deeren, Evy Billen, Kasper Croese, Jesse Tettero, Patrycja Gradowska, Bob Löwenberg, Gert Ossenkoppele, Jeroen J. W. M. Janssen, Jacqueline Cloos, David de Leeuw, & Catharina Van Elssen. (June 2025). (PS1481) SECOND INDUCTION CYCLE BEFORE ALLOHSCT DOES NOT IMPROVE SURVIVAL IN ADVERSE-RISK AML PATIENTS IN COMPLETE REMISSION AFTER FIRST INDUCTION. HemaSphere, 9 (S1). doi:10.1002/hem3.70152

De Voeght, A.* , KOOPMANSCH, B.* , MENTEN, C., Fernandez Carazo, R., Keutgens, A., Tassin, F., Somja, J., Collins, P., SIMUL, M., DE PRIJCK, B., Foguenne, J.* , & LETE, C.*. (07 February 2025). Aggressive Hematological Neoplasms Involving Plasmacytoid Dendritic Cells: A Three-Case Serie [Poster presentation]. 40th General Annual Meeting of the Belgian Hematology Society 2025.
* These authors have contributed equally to this work.

De Voeght, A., Aaron D. Goldberg, Florence Van Obbergh, Nathan De Beule, Laura Vandeweerd, Barbara Gillon, Yanqing Xu, Rebecca Burne, & Johan Maertens. (2025). OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX AND AZACITIDINE IN REAL-WORLD BELGIAN CLINICAL PRACTICE [Poster presentation]. EHA2025.

GILLARD, R., Jadoul, A., De Voeght, A., & PONGHIS, G. (2025). Cas clinique : masse médiastinale prévasculaire. Revue Médicale de Liège, 80, 12-17.

De Voeght, A. (06 November 2024). Fungal Infections in Hematology [Paper presentation]. Joint Meeting SFMM – BSHAM.

Pirnay, J.-P., Djebara, S., Steurs, G., Griselain, J., Cochez, C., De Soir, S., Glonti, T., Spiessens, A., Vanden Berghe, E., Green, S., Wagemans, J., Lood, C., Schrevens, E., Chanishvili, N., Kutateladze, M., de Jode, M., Ceyssens, P.-J., Draye, J.-P., Verbeken, G., ... Guiot, J. (Other coll.). (2024). Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nature Microbiology. doi:10.1038/s41564-024-01705-x

Dierickx, D., Connerotte, T., Dallemagne, J., De Becker, A., Moors, I., Snauwaert, S., Sonet, A., Theunissen, K., Breems, D., De Voeght, A., JASPERS, A., Lambert, C., Heyrman, B., Hautekiet, J., Lyna, S., Maertens, C., & Delrieu, V. (2024). Real-World Insights on the Management of Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) With Caplacizumab. Blood Vessels, Thrombosis and Hemostasis, 100008. doi:10.1016/j.bvth.2024.100008

De Voeght, A. (02 February 2024). AML: new therapies - current and future [Paper presentation]. 39th General Annual Meeting of the Belgian Hematology Society 2024.

SAKALIHASAN, S., LIFRANGE, F., CZAJKOWSKI, M., GONCETTE, V., Duysinx, B., Lovinfosse, P., Can, D., Schils, R., Hayette, M.-P., & De Voeght, A. (2024). Severe Dual Fungal Infection After Bispecific Antibody Therapy: A Case of Invasive Aspergillosis and Mucormycosis in Immunocompromised Patient. IDCases, 39, 02140. doi:10.1016/j.idcr.2024.e02140

De Voeght, A., WILLEMS, E., Servais, S., Seidel, L., Pirotte, M., Massion, P., Layios, N., Pereira, M., Misset, B., CANIVET, J.-L., Beguin, Y., & Baron, F. (31 August 2022). Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores. Cancers, 14 (17), 4266. doi:10.3390/cancers14174266

DE VOEGHT, A. (15 October 2021). Thrombotic Microvascular Injury is not Mediated by Thrombotic Micro Angiopathy Despite Systemic Complement Activation in COVID-19 Patients. Journal of Blood Disorders and Transfusion, 12.

DE VOEGHT, A., JASPERS, A., BEGUIN, Y., Baron, F., & DE PRIJCK, B. (2021). Principes généraux de la prise en charges des leucémies aiguës de l’adulte en 2021 en Belgique. Revue Médicale de Liège, 76, 470-475.

DE VOEGHT, A., CALMES, D., BECK, F., SYLVESTRE, J.-B., DELVENNE, P., PETERS, P., VERTENOEIL, G., BARON, F., LAYIOS, N., & CANIVET, J.-L. (2020). Thrombotic microvascular injury is not mediated by thrombotic microangiopathy despite systemic complement activation in Covid-19 patients. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/256301.

DE VOEGHT, A., Godon, E., Chachati, A., CAVALIER, E., & Buysschaert, B. (2019). HYPERCALCÉMIE SUR INTOXICATION À LA VITAMINE D : VIGNETTE CLINIQUE ET REVUE DE LA LITTÉRATURE. Louvain Medical.

Delmotte, V., Foidart, P., DE VOEGHT, A., LEJEUNE, M., & Delwaide, J. (2019). Diagnostic différentiel de l’anémie dans la cirrhose éthylique. Revue Médicale de Liège, 74 (10), 527-534.

Schweich, M., DE VOEGHT, A., Sacre, F., BERNARD, V., & Michels, V. (2018). Scorbut, maladie historique ? Revue Médicale de Liège, 73:11, 541-543.

DE VOEGHT, A., Martens, H., RENARD, J. D. C., VAIRA, D., Debruche, M., Simonet, J., Geenen, V., MOUTSCHEN, M., & DARCIS, G. (2017). Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium. PLoS ONE. doi:10.1371/journal.pone.0185761

DE VOEGHT, A., Maes, N., & Moutschen, M. (27 March 2016). sCD14 is not a bona-fide biomarker of microbial translocation in HIV-1 infected Africans living in Belgium. AIDS, 30 (6), 921-4. doi:10.1097/QAD.0000000000000996

DE VOEGHT, A., SAUVAGE, A.-S., GENSBURGER, M., GIOT, J.-B., & Moutschen, M. (2016). Tuberculose miliaire chez une patiente sous adalimumab. Revue Médicale de Liège, 71 (7-8), 328-331.

Pirotte, B., Rassenfosse, M., Collin, R., De Voeght, A., MOUTSCHEN, M., & CAVALIER, E. (2013). Rôle de la vitamine D dans l'infection par le VIH: revue des connaissances actuelles. Revue Médicale de Liège, 68 (1), 25-31.